EPLUS INC
For the period ended Mar 31, 2026. Filed May 28, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed May 28, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
FORM 10-K SUMMARY
None.
SIGNATURES
Pursuant to the requirements of Section 13 or Section 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
ePlus inc.
/s/ MARK P. MARRON
By: Mark P. Marron
Chief Executive Officer and President
Date: May 28, 2026
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
/s/ MARK P. MARRON
By: Mark P. Marron
Chief Executive Officer, President, and Director (Principal Executive Officer)
Date: May 28, 2026
/s/ ELAINE D. MARION
By: Elaine D. Marion, Chief Financial Officer
(Principal Financial and Accounting Officer)
Date: May 28, 2026
/s/ MELISSA J. BALLENGER
By: Melissa J. Ballenger, Director
Date: May 28, 2026
/s/ RENÉE BERGERON
By: Renée Bergeron, Director
Date: May 28, 2026
/s/ BRUCE M. BOWEN
By: Bruce M. Bowen, Director
Date: May 28, 2026
/s/ JOHN E. CALLIES
By: John E. Callies, Director
Date: May 28, 2026
/s/ IRA A. HUNT III
By: Ira A. Hunt III, Director
Date: May 28, 2026
/s/ MAUREEN F. MORRISON
By: Maureen F. Morrison, Director
Date: May 28, 2026
/s/ MICHAEL J. PORTEGELLO
By: Michael J. Portegello, Director
Date: May 28, 2026
INDEX TO FINANCIAL STATEMENTS AND SCHEDULES
| PAGE | |
| Report of Independent Registered Public Accounting Firm Deloitte & Touche LLP (PCAOB ID 34) | F-2 |
|---|---|
| Consolidated Balance Sheets as of March 31, 2026, and 2025 | F-7 |
| Consolidated Statements of Operations for the years ended March 31, 2026, 2025 and 2024 | F-8 |
| Consolidated Statements of Comprehensive Income for the years ended March 31, 2026, 2025 and 2024 | F-9 |
| Consolidated Statements of Cash Flows for the years ended March 31, 2026, 2025 and 2024 | F-10 |
| Consolidated Statements of Stockholders’ Equity for the years ended March 31, 2026, 2025 and 2024 | F-12 |
| Notes to Consolidated Financial Statements | F-13 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.